European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome : The SHARE initiative
Groot, Noortje; De Graeff, Nienke; Avcin, Tadej; Bader-Meunier, Brigitte; Dolezalova, Pavla; Feldman, Brian M.; Kenet, Gili; Koné-Paut, Isabelle; Lahdenne, Pekka; Marks, Stephen D; McCann, Liza J.; Pilkington, Clarissa A.; Ravelli, Angelo; Van Royen-Kerkhof, Annet; Uziel, Yosef; Vastert, Sebastiaan J.; Wulffraat, Nico M.; Ozen, Seza; Brogan, Paul A.; Kamphuis, Sylvia; Beresford, Michael W.
(2017) Annals of the Rheumatic Diseases, volume 76, issue 10, pp. 1637 - 1641
(Article)
Abstract
Antiphospholipid syndrome (APS) is rare in children, and evidence-based guidelines are sparse. Consequently, management is mostly based on observational studies and physician's experience, and treatment regimens differ widely. The Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative was launched to develop diagnostic and management regimens for
... read more
children and young adults with rheumatic diseases. Here, we developed evidencebased recommendations for diagnosis and treatment of paediatric APS. Evidence-based recommendations were developed using the European League Against Rheumatism standard operating procedure. Following a detailed systematic review of the literature, a committee of paediatric rheumatologists and representation of paediatric haematology with expertise in paediatric APS developed recommendations. The literature review yielded 1473 articles, of which 15 were valid and relevant. In total, four recommendations for diagnosis and eight for treatment of paediatric APS (including paediatric Catastrophic Antiphospholipid Syndrome) were accepted. Additionally, two recommendations for children born to mothers with APS were accepted. It was agreed that new classification criteria for paediatric APS are necessary, and APS in association with childhoodonset systemic lupus erythematosus should be identified by performing antiphospholipid antibody screening. Treatment recommendations included prevention of thrombotic events, and treatment recommendations for venous and/or arterial thrombotic events. Notably, due to the paucity of studies on paediatric APS, level of evidence and strength of the recommendations is relatively low. The SHARE initiative provides international, evidencebased recommendations for diagnosis and treatment for paediatric APS, facilitating improvement and uniformity of care.
show less
Download/Full Text
Not available. The author may have various reasons for not providing access, for instance because it is prohibited by the commissioner of the research, or because the author is conducting further research on the subject.
Author keywords: Rheumatology, Immunology and Allergy, Immunology, Biochemistry, Genetics and Molecular Biology(all)
ISSN: 0003-4967
(Publisher version, Peer reviewed)
See more statistics about this item